(Q28570836)

31 January 2017

title

Increased "peripheral-type" benzodiazepine receptor sites and mRNA in thalamus of thiamine-deficient rats (English)

1 reference

31 January 2017

4

R. F. Butterworth

1 reference

31 January 2017

P. Desjardins

1

1 reference

31 January 2017

K. G. Todd

series ordinal

2

1 reference

31 January 2017

A. S. Hazell

series ordinal

3

1 reference

31 January 2017

language of work or name

1 reference

1 November 1999

1 reference

Neurochemistry International

31 January 2017

published in

1 reference

31 January 2017

volume

35

1 reference

31 January 2017

issue

5

1 reference

31 January 2017

page(s)

363–369

1 reference

Low energy levels in thiamine-deficient encephalopathy.

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Pathophysiologic mechanisms responsible for the reversible (thiamine-responsive) and irreversible (thiamine non-responsive) neurological symptoms of Wernicke's encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Effect of pyrithiamine treatment and subsequent thiamine rehabilitation on regional cerebral amino acids and thiamine-dependent enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Thiamine deficiency and wernicke's encephalopathy in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Blood-Brain Barrier Abnormalities in Vulnerable Brain Regions during Thiamine Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Mamillary body atrophy in Wernicke's encephalopathy: antemortem identification using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Cerebral vulnerability is associated with selective increase in extracellular glutamate concentration in experimental thiamine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Increased densities of binding sites for the "peripheral-type" benzodiazepine receptor ligand [3H]PK11195 in vulnerable regions of the rat brain in thiamine deficiency encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

The nucleotide sequence of the rat cytoplasmic β–actin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

[3H]R05-4864 and [3H]flunitrazepam binding in kainate-lesioned rat striatum and in temporal cortex of brains from patients with senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Characterization of benzodiazepine binding sites in cultured cells of neural origin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Increased neuronal cell survival after L-deprenyl treatment in experimental thiamine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Brain lesions in alcoholics. A neuropathological study with clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Model of Wernicke's Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Early edematous lesion of pyrithiamine induced acute thiamine deficient encephalopathy in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2899%2900082-0

7 January 2021

10.1016/S0197-0186(99)00082-0

Identifiers

DOI

0 references

1 reference